Pediatric trauma mortality in India and the United States: A comparison and risk-adjusted analysis

Stas Amato1, Katherine Culbreath2, Emma Dunne3

  • 1Department of Surgery, University of Vermont Medical Center, 111 Colchester Ave, Burlington, VT 05401, USA.

Insights

Pediatric trauma mortality is significantly higher in India than in the US, especially for children with less severe injuries. Improving trauma care protocols in India could save young lives.

Area of Science:

  • Global Health
  • Trauma Surgery
  • Pediatric Critical Care

Background:

  • Limited research exists on pediatric trauma mortality disparities between high-income and low- to middle-income countries.
  • This knowledge gap hinders targeted interventions for specific populations and injury patterns.

Purpose of the Study:

  • To compare independent predictors of pediatric trauma mortality between India and the United States (US).

Main Methods:

  • Retrospective cohort study of pediatric trauma patients (<18 years) from India (TITCO) and US (NTDB) databases (2013-2015).
  • Analysis of demographic, injury, physiologic, and outcome data.
  • Multivariable regression models to identify independent mortality predictors.

Main Results:

  • 126,678 patients included (India: 3,373; US: 123,305).
  • Indian pediatric trauma patients were younger, had higher injury severity scores, lower blood pressure, and a higher case fatality rate (13.0% vs. 1.0%).
  • Injury in India was the strongest mortality predictor (OR 22.70); highest mortality odds were in children with lower injury and physiologic severity.

Conclusions:

  • Risk-adjusted pediatric trauma mortality is substantially higher in India compared to the US.
  • Disparities are most pronounced in children with less severe injuries, suggesting systemic care differences.
  • Low-cost interventions in trauma care, protocols, training, and imaging may reduce pediatric injury mortality in India.
Abstract

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
250
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
289
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
113
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
158
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
215